CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Kuromanine 25mg  | ≥98%

CSNpharm

Kuromanin, a natural product isolated and purified from the herbs of Chrysanthemum indicum, has been shown to improve blood glucose concentrations and lipid homeostasis and to reduce obesity.

More Information Supplier Page

Kuromanine 5mg  | ≥98%

CSNpharm

Kuromanin, a natural product isolated and purified from the herbs of Chrysanthemum indicum, has been shown to improve blood glucose concentrations and lipid homeostasis and to reduce obesity.

More Information Supplier Page

Kushenol A 1mg  | ≥98%

CSNpharm

Kushenol A, a kind of Adenosine 3′, 5′-cyclic monophosphate(cAMP)phosphodiesterase inhibitiors isolated and purified from the roots of Sophora flavescens Ait., exhibits inhibitory activity against sodium-dependent glucose cotransporter 2(SGLT2 and shows selective alpha-glucosidase inhibitory activity.

More Information Supplier Page

Kushenol A 5mg  | ≥98%

CSNpharm

Kushenol A, a kind of Adenosine 3′, 5′-cyclic monophosphate(cAMP)phosphodiesterase inhibitiors isolated and purified from the roots of Sophora flavescens Ait., exhibits inhibitory activity against sodium-dependent glucose cotransporter 2(SGLT2 and shows selective alpha-glucosidase inhibitory activity.

More Information Supplier Page

Kuwanon A 2mg  | ≥97%

CSNpharm

Kuwanon A is a flavone derivative isolated from the root barks of the mulberry tree (Morus alba L.) and inhibits nitric oxide production with IC50 of 10.5 μM.

More Information Supplier Page

Kuwanon A 5mg  | ≥97%

CSNpharm

Kuwanon A is a flavone derivative isolated from the root barks of the mulberry tree (Morus alba L.) and inhibits nitric oxide production with IC50 of 10.5 μM.

More Information Supplier Page

Kuwanon A 25mg  | ≥97%

CSNpharm

Kuwanon A is a flavone derivative isolated from the root barks of the mulberry tree (Morus alba L.) and inhibits nitric oxide production with IC50 of 10.5 μM.

More Information Supplier Page

Kuwanon A 10mg  | ≥97%

CSNpharm

Kuwanon A is a flavone derivative isolated from the root barks of the mulberry tree (Morus alba L.) and inhibits nitric oxide production with IC50 of 10.5 μM.

More Information Supplier Page

Kuwanon E 5mg  | ≥98%

CSNpharm

Kuwanon E is a flavonoid that isolated from the root bark of Morus alba L. with anti-stress and diuretic effect.

More Information Supplier Page

Kuwanon E 1mg  | ≥98%

CSNpharm

Kuwanon E is a flavonoid that isolated from the root bark of Morus alba L. with anti-stress and diuretic effect.

More Information Supplier Page

Kuwanon E 2mg  | ≥98%

CSNpharm

Kuwanon E is a flavonoid that isolated from the root bark of Morus alba L. with anti-stress and diuretic effect.

More Information Supplier Page

KY 12420 10mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

KY 12420 5mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

KY 12420 1mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

KY 12420 25mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

KYA1797K 100mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

KYA1797K 25mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

KYA1797K 1mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

KYA1797K 5mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

KYA1797K 10mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

KYA1797K 50mg  | ≥99%

CSNpharm

KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).

More Information Supplier Page

L-(-)-α-Methyldopa HCl 100mg  | ≥98%

CSNpharm

L-(-)-α-Methyldopa HCl is an alpha-adrenergic agonist (selective for α2-adrenergic receptors) psychoactive drug used as a sympatholytic or antihypertensive.

More Information Supplier Page

L-(-)-α-Methyldopa HCl 1g  | ≥98%

CSNpharm

L-(-)-α-Methyldopa HCl is an alpha-adrenergic agonist (selective for α2-adrenergic receptors) psychoactive drug used as a sympatholytic or antihypertensive.

More Information Supplier Page

L-2-Hydroxyglutaric acid disodium 100mg  | ≥95%

CSNpharm

L-2-Hydroxyglutaric acid disodium is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid disodium can inhibit histone demethylases and hence promote histone methylation. L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with Km and Ki of 2.52 mM and 11.13 mM, respectively.

More Information Supplier Page

L-701,324 25mg  | ≥98%

CSNpharm

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor.

More Information Supplier Page

L-701,324 10mg  | ≥98%

CSNpharm

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor.

More Information Supplier Page

L-701,324 50mg  | ≥98%

CSNpharm

L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor.

More Information Supplier Page

L-732138 1mg  | ≥99%

CSNpharm

L-732138 is a potent and highly selective competitive tachykinin NK1 receptor antagonist with IC50 of 2.3 nM.

More Information Supplier Page

L-732138 5mg  | ≥99%

CSNpharm

L-732138 is a potent and highly selective competitive tachykinin NK1 receptor antagonist with IC50 of 2.3 nM.

More Information Supplier Page

L-745870 10mg  | ≥98%

CSNpharm

L-745870 is a high-affinity, selective and orally active human dopamine D4 receptor antagonist with a Ki of 0.43 nM and excellent brain penetration.

More Information Supplier Page

L-745870 5mg  | ≥98%

CSNpharm

L-745870 is a high-affinity, selective and orally active human dopamine D4 receptor antagonist with a Ki of 0.43 nM and excellent brain penetration.

More Information Supplier Page

L-765314 100mg  | ≥99%

CSNpharm

L-765314 is a potent and selective α1b adrenergic receptor antagonist with Kis of 5.4±0.6 nM and 2.0±0.66 nM for rat and human α1b adrenergic receptor, respectively.

More Information Supplier Page

L-765314 5mg  | ≥99%

CSNpharm

L-765314 is a potent and selective α1b adrenergic receptor antagonist with Kis of 5.4±0.6 nM and 2.0±0.66 nM for rat and human α1b adrenergic receptor, respectively.

More Information Supplier Page

L-765314 10mg  | ≥99%

CSNpharm

L-765314 is a potent and selective α1b adrenergic receptor antagonist with Kis of 5.4±0.6 nM and 2.0±0.66 nM for rat and human α1b adrenergic receptor, respectively.

More Information Supplier Page